Tenet Healthcare Corporation (THC) — ESG & Values Scores

Environment story

Tenet Healthcare discloses minimal environmental data. No Scope 1, 2, or 3 emissions metrics are reported in the 10-K. No net-zero target year is disclosed. The company acknowledges AI and generative AI adoption for operational efficiency but does not quantify energy or carbon impacts. No renewable energy percentage disclosed. No major environmental controversies (toxic waste, water, habitat) are evident in the filing. The company does not provide credible decarbonization initiatives or physical infrastructure investments. Greenwashing risk is moderate: absence of disclosed emissions data and targets, combined with limited transparency on environmental governance, suggests environmental issues are not material to disclosed strategic disclosures. No evidence of carbon-offset reliance or Scope 3 supply-chain emissions management.

Criticisms on file

No material criticisms on file for this pillar.

Disclosed initiatives

AI and Generative AI Adoption

Acceleration of AI-enabled tools in clinical care coordination, medical documentation, revenue cycle management and administrative services to enhance business processes and support efficient delivery of care.

Social story

Tenet Healthcare reports approximately 20% union representation among Hospital Operations segment employees as of December 31, 2025, primarily registered nurses and service/technical/maintenance workers at 27 hospitals, concentrated in California, Florida, and Michigan. The company acknowledges ongoing labor shortages, wage pressures from state-mandated minimum wage increases (California healthcare workers), and competition for experienced nurses and advanced practice clinicians. Recent strikes and work stoppages are referenced as potential risks but no specific documented strike within the last 24 months is disclosed in the 10-K. The company notes physician recruitment and retention challenges in 2025, particularly in higher-demand specialties. CEO-to-median-worker pay ratio is not disclosed; estimate cannot be computed from available data. Leadership diversity metrics (executive/board representation by gender, race) are not disclosed. The company operates a charity care program and 'Compact with Uninsured Patients' offering discounts to uninsured patients, suggesting social commitment to access. No evidence of active union suppression or NLRB violations in the filing. Supply-chain audits for human rights hazards are not disclosed.

Criticisms on file

No material criticisms on file for this pillar.

Disclosed initiatives

Physician Recruitment and Retention

Ongoing efforts to attract and recruit quality physicians in specialties required to support hospital services; support provided through appropriate facilities, equipment, and compensation within Anti-kickback Statute and Stark law constraints.

2025 experienced continued challenges in recruiting and retaining physicians; regional shortages in higher-demand specialties affected recruitment.
Eligibility and Enrollment Services (EES) Program

Patient advocates screen patients to determine eligibility for financial assistance and government programs; expedite Medicaid application process. Approximately 98% of accounts in EES ultimately approved for government program benefits.

Supports access to care for low-income and uninsured populations; reduces uncompensated care burden.
Charity Care and Uninsured Discount Programs

Financial assistance provided to uninsured patients unable to pay for healthcare services; amounts determined to qualify for financial assistance are not pursued for collection and not reported in net operating revenues.

Estimated costs of caring for uninsured and charity patients: $573 million in 2025 (down from $617 million in 2024).

Governance story

Tenet Healthcare operates with a single-class share structure (no dual-class voting disclosed), mitigating governance risk from founder supermajority control. Board independence percentage is not disclosed in the 10-K filing, limiting assessment against the 75% benchmark; standard practice for healthcare systems suggests likely compliance, but absence of explicit disclosure is a governance transparency gap. Annual lobbying expenditures are not disclosed; the company does not identify active lobbying targeting environmental deregulation or consumer-protection rollbacks. The company is not subject to active major antitrust proceedings, consumer-safety enforcement, or financial-fraud regulatory actions disclosed in the 10-K. However, the filing does reference cybersecurity incident in April 2022 involving data exfiltration and disruption; elevated cyber-attack risk acknowledged, and company has increased cyber insurance premiums. Litigation and investigation costs totaled $64 million in 2025 versus $35 million in 2024, indicating elevated legal exposure. No evidence of shareholder lawsuits specifically blocking climate proposals or ESG initiatives. Governance structure appears standard for large healthcare provider; transparency on board composition and lobbying activities is limited.

Criticisms on file

April 2022 Cybersecurity Incident: Ransomware attack and data exfiltration involving confidential company and patient information; disrupted subset of hospital operations.
Source: THC 10-K, Risk Factors section, Cybersecurity Risks; Item 7 MD&A acknowledges April 2022 incident and ongoing elevated cyber threat environment.
Elevated Litigation and Investigation Costs: Litigation and investigation costs increased from $35 million (2024) to $64 million (2025), indicating material increase in legal exposure and settlements.
Source: THC 10-K, Consolidated Results of Operations table, year ended December 31, 2025.

Disclosed initiatives

Capital Structure Management and Debt Refinancing

November 2025: executed new senior secured revolving credit facility with increased borrowing capacity and favorable terms. Issued $1.5 billion of 5.5% senior secured notes (due 2032) and $750 million of 6% senior unsecured notes (due 2033); redeemed $1.5 billion of second lien notes (due Feb 2027) and $750 million of senior unsecured notes (due Oct 2028) in advance of maturity.

Staggered debt maturity profile (2027–2033) reduces refinancing risk; fixed-rate debt structure minimizes interest rate volatility exposure.
Cybersecurity Risk Mitigation

Ongoing investment in security measures, incident detection, prevention and mitigation, remediation of system vulnerabilities, and new technology to mitigate security risks. Company continues to expend significant resources on cyber defense infrastructure.

April 2022 incident triggered increased cyber insurance premiums and reduced coverage; elevated vigilance on third-party vendor security and AI/Generative AI security risks acknowledged.
Share Repurchase Program

Active share repurchase program with no expiration date and no obligation to acquire any particular amount. Repurchased $1.386 billion of common stock in 2025; $1.490 billion available for future repurchases.

Returns capital to shareholders; no material impact on governance structure or voting rights.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Tenet Healthcare Corporation. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Tenet Healthcare Corporation in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)